Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov 6;326(5954):871-4.
doi: 10.1126/science.1177627.

A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire

Affiliations

A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire

Baomei Wang et al. Science. .

Abstract

Pathogen recognition by T cells is dependent on their exquisite specificity for self-major histocompatibility complex (MHC) molecules presenting a bound peptide. Although this specificity results from positive and negative selection of developing T cells in the thymus, the relative contribution of these two processes remains controversial. To address the relation between the selecting peptide-MHC complex and the specificity of mature T cells, we generated transgenic mice that express a single peptide-MHC class I complex. We demonstrate that positive selection of CD8 T cells in these mice results in an MHC-specific repertoire. Although selection on a single complex is peptide promiscuous, mature T cells are highly peptide specific. Thus, positive selection imparts MHC and peptide specificity on the peripheral CD8 T cell repertoire.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
SCT 3KO primary CTLs are Kb-specific and non-MHC cross-reactive. (A) OVAp/Kb SCT 3KO splenocytes stimulated with B6 splenocytes were cultured with RMA (H2b) target cells in the absence or presence of mAb. Data represent one experiment of 6. (B) OVAp/Kb SCT 3KO anti-B6 CTL clones were cultured with RMA (Kb+Db+), RMA.S (TAP−/−, H2b) or R8.15 (Kb−Db+) target cells. Data represent one experiment of 3. (C) Kb-reactive CTLs generated from control Kb−/−Db+/+ splenocytes and SCT 3KO splenocytes, stimulated with Kb+/+Db−/− splenocytes, were replated with indicated stimulator cells. Production of intracellular IFN-γ by CD8+ T cells was measured by flow cytometry. Data represent one experiment of 3. (D) CTL clones were generated from SCT 3KO mice and Kb−/−Db+/+ mice stimulated with B6. The CTL clones were cultured with RMA (H2b), P815 (H2d), or R1.1 (H2k) target cells. Data are one representative experiment. Clones were assayed 2 to 4 times.
Fig. 2
Fig. 2
Recognition by SCT 3KO mice of Kb endogenous peptides complexed with H2-Kb. (A) The sequences of the 90 Kb-binding peptides are listed based on their ability to stimulate polyclonal T cells from the two strains of SCT 3KO mice. Peptides were assayed at least 3 times. (B) Kb binding was measured using an MHC class I surface induction assay as described (29). Binding is plotted as the concentration of peptide that resulted in a threefold increase in the expression level of Kb on RMA.S cells. The bar indicates the mean peptide concentration. Data represent one experiment of 3.
Fig. 3
Fig. 3
SCT-selected cells are highly peptide-specific. Splenocytes from OVAp/Kb SCT 3KO mice were stimulated with 6 different peptides, indicated at the top of each panel, and tested with the stimulating peptide and 18 other peptides as indicated. Data represent one experiment of 3.
Fig. 4
Fig. 4
T cell responses to differentially recognized peptides. (A) Primary SCT 3KO CTLs, stimulated with peptides recognized exclusively by OVAp/Kb (SAMVFSAM) or VSV/Kb (YQYSFPEL), were tested for reactivity over a range of peptide concentrations. Data represent one experiment of 3. (B) The same peptides in (A) were used to generate CTLs from OVAp/Kb SCT 3KO, VSVp/Kb SCT 3KO and (OVAp/Kb × VSVp/Kb) F1 SCT 3KO mice and were tested for lysis of peptide-treated RMA.S target cells. Data represent one experiment of 3.

Similar articles

Cited by

References

    1. Hogquist KA, Gavin MA, Bevan MJ. J Exp Med. 1993;177:1469. - PMC - PubMed
    1. Hogquist KA, et al. Cell. 1994;76:17. - PubMed
    1. Ashton-Rickardt PG, Van Kaer L, Schumacher TN, Ploegh HL, Tonegawa S. Cell. 1993;73:1041. - PubMed
    1. Ashton-Rickardt PG, et al. Cell. 1994;76:651. - PubMed
    1. Sebzda E, et al. Science. 1994;263:1615. - PubMed

Publication types

MeSH terms